Surgical treatment of non-small-cell lung cancer in octogenarians: a single-centre retrospective study

被引：7
|
作者：
Chen, Charlotte [1 ]
Kolbe, John [1 ,2 ]
Christmas, Tim [1 ]
机构：
[1] Auckland Dist Hlth Board, Resp Serv, Auckland, New Zealand
[2] Univ Auckland, Dept Med, Auckland, New Zealand
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 04期
关键词：
lung cancer; octogenarian; lung resection; ELDERLY-PATIENTS; RISK;
D O I：
10.1111/imj.15268
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lung resection in patients aged >= 80 years is considered high risk and contributes to the low rates of resection in this population. This review of 79 octogenarians who underwent curative surgery for non-small-cell lung cancer demonstrated no intraoperative mortality, 30-day mortality of 1.3% and 12-month mortality of 10%. In this selected cohort of octogenarians, surgery resulted in acceptable short- to medium-term outcomes.
引用
收藏
页码：596 / 599
页数：4
相关论文
共 50 条
  • [31] Crizotinib in the Treatment of Non-Small-Cell Lung Cancer
    Rothschild, Sacha I.
    Gautschi, Oliver
    CLINICAL LUNG CANCER, 2013, 14 (05) : 473 - 480
  • [32] Gefitinib for the treatment of non-small-cell lung cancer
    Campbell, Lynn
    Blackhall, Fiona
    Thatcher, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
  • [33] Bevacizumab in the treatment of non-small-cell lung cancer
    Stinchcombe, T. E.
    Socinski, M. A.
    ONCOGENE, 2007, 26 (25) : 3691 - 3698
  • [34] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [35] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
    Garon, Edward B.
    Rizvi, Naiyer A.
    Hui, Rina
    Leighl, Natasha
    Balmanoukian, Ani S.
    Eder, Joseph Paul
    Patnaik, Amita
    Aggarwal, Charu
    Gubens, Matthew
    Horn, Leora
    Carcereny, Enric
    Ahn, Myung-Ju
    Felip, Enriqueta
    Lee, Jong-Seok
    Hellmann, Matthew D.
    Hamid, Omid
    Goldman, Jonathan W.
    Soria, Jean-Charles
    Dolled-Filhart, Marisa
    Rutledge, Ruth Z.
    Zhang, Jin
    Lunceford, Jared K.
    Rangwala, Reshma
    Lubiniecki, Gregory M.
    Roach, Charlotte
    Emancipator, Kenneth
    Gandhi, Leena
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2018 - 2028
  • [36] Selumetinib in the treatment of non-small-cell lung cancer
    Bernabe, Reyes
    Patrao, Ana
    Carter, Louise
    Blackhall, Fiona
    Dean, Emma
    FUTURE ONCOLOGY, 2016, 12 (22) : 2545 - 2560
  • [37] Bevacizumab in the treatment of non-small-cell lung cancer
    T E Stinchcombe
    M A Socinski
    Oncogene, 2007, 26 : 3691 - 3698
  • [38] Systemic treatment of non-small-cell lung cancer
    Lal, Rohit
    Enting, Deborah
    Kristeleit, Hartmut
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S375 - S377
  • [39] Erlotinib in the treatment of non-small-cell lung cancer
    Kyte, J.
    Wilson, P. C.
    Dangoor, A.
    LUNG CANCER, 2012, 75 : S6 - S7
  • [40] Gemcitabine in the treatment of non-small-cell lung cancer
    Burkes, RL
    Shepherd, FA
    ANNALS OF ONCOLOGY, 1995, 6 : 57 - 60
12345